Johnson & Johnson Announces Start of Safety and Immunogenicity Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
October 09, 2015 at 04:21 AM EDT
Johnson & Johnson (NYSE: JNJ) today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a ...